3SOF

INSM seems to breakout today.

Bought at 1,30.

Long term INSM may be a tenbagger.

http://bigcharts.marketwatch.com/javachart/javachart.asp?symb=insm&time=&freq=

News:Lazard initiate INSM with $2.50 target


Initiating coverage on the two GHIS contenders
1. Growth Hormone Insensitivity (GHIS), or severe short stature, is a subset of
the $2 billion growth hormone therapy market; no approved therapies to date
2. Tercica's Increlex and Insmed's SomatoKine are both expected to receive
approval, with PDUFA dates of August 31 and October 3, 2005, respectively
3. Pediatric endocrinologists we interviewed favor Insmed's SomatoKine over
Tercica's Increlex, should both be launched concurrently, as we expect
4. INSM (current price: $1.22) is rated BUY with a $2.50 price target, as we
believe the shares are undervalued; any significant and/or lasting concern over
Increlex approval would be misplaced
5. TRCA (current price: $8.57) is rated HOLD with a $9.50 price target, as we
consider the shares to be fully valued and vulnerable to nearly any
disappointment; any regulatory delays could trigger a decline
6. Risks to INSM include potential orphan drug exclusivity for Tercica's
Increlex if approved first, while TRCA investors may be disappointed, as we
expect Increlex market acceptance to be low upon commercialization of both
products

therman

INSM begins to fly. now at 1,55.

I think this is only the beginning.

http://data.inetats.com/ds/tools/bookviewer/htmlbook.jsp?STOCK=insm

therman

 :-\Kind of empty on this board...

I've got myself and at least three relatives in this stock. Waiting like everyone else. Small stake, just getting started in some real market play. Would consider myself a semi-market wise newbie, but have made some good picks in the past. Here to learn...quick!!! I think this stock has blockbuster potential, both near and long term. Did you pick up on any of the Bio conference presentation material?

Looks like approval w/orphan is expected by management and soon. Several partner candidates referenced but not by name, iPLEX is being produced at the Boulder facility and we're ready to rock. I go by the same id on the yahoo INSM board. Also following NVAX.

Check back tomorrow for signs of life...

Regards

Quote from: retvet24 on October 20, 2005, 10:59:34 PM
:-\Kind of empty on this board...

Looks like approval w/orphan is expected by management and soon. Several partner candidates referenced but not by name, iPLEX is being produced at the Boulder facility and we're ready to rock. I go by the same id on the yahoo INSM board. Also following NVAX.

Check back tomorrow for signs of life...

Not exactly tomorrow, but INSM is putting in support around $1.20 now for a week. May be a small drop to $1.15 as the wait to Dec. 12th FDA announcement drags out, but the bottom is here IMHO. The approval PR may catch people off guard, as did the "approvable" letter. I plan on getting back in post Thanksgiving-1st week Dec. with some cash extracted from NVAX.

These two stocks are about as close as I can find to "sure things"...

Regards....

Check back later for signs of life...

Regards

FDA is ok today...insm WINNER...LIVELIFE come on $$$$$




That's made$$$$$$$$$$$$$$$$$$$$$$$$$$$

There is a very good chance that the FDA will grant orphan-drug status to INSM's iPlex on 12/12/05. The company CEO seems to think so. This recent company presentation will give you some clues.

I believe that INSM will go up substantially today, Friday Dec. 9, 2005.

And there might be more news soon. From the Yahoo board:



INSM & Breast Cancer Conf. on 12/10th
by: pix_with_x
Long-Term Sentiment: Strong Buy  12/09/05 03:42 am
Msg: 35698 of 35700

Just as a reminder! INSM to present on 10th in San Antonio...And have a short look who will be present...Not the smallest ones!

http://sabcs.org/programschedule/postersessions.asp?sessiongroupid=21
Post 5081: Synergistic interaction between recombinant human insulin-like growth factor-binding protein 3 (rhIGFBP-3) and letrozole in estrogen positive breast cancer.
Alami N, Banerjee K, Page V, Brossard M, Shiry L, Brodie A, Leyland-Jones B. McGill University, Montreal, QC, Canada; Insmed Inc., Richmond, VA; University of Maryland, Baltimore, MD.

Ch, PwX

Nervous about waiting...Good or ..............bad news ...
Today, we're gonna see !

Good luck 

 

FDA's approval is good.....
So....don't miss the bus..............................$$$$$$$$$$$$$

Got in AH @2.14 This one might run some more tomorrow.

Looking for 3.00 tomorrow.




AP
Insmed Shares Soar on FDA OK of Iplex
Monday December 12, 6:26 pm ET

Insmed Shares Climb 40.3 Percent After FDA OKs Iplex Therapy, Grants Treatment 'Orphan' Status


RICHMOND, Va. (AP) -- Insmed Inc. said Monday that regulators approved its Iplex therapy for children who lack a certain growth hormone and granted the treatment "orphan drug" status despite the approval of a competing drug.




As recently as October, Insmed said the Food and Drug Administration was still considering whether to make Iplex an orphan drug. The label, which carries seven years of exclusive selling rights, is designed to motivate companies to develop treatments for rare diseases.

Insmed shares surged 40.3 percent after-hours to $2.09, having closed on the Nasdaq up 2 percent at $1.49.

The drug was approved to boost the height of children with a severe deficiency of a hormone called IGF-1, or whose bodies cannot recognize growth hormones. It is delivered in a daily dose.

Insmed plans to launch the drug between April and June. Competitor Tercica Inc. received FDA approval and orphan drug exclusivity for its similar growth hormone, Increlex, in September to treat a severe deficiency of IGF-1.

Up 44% Ah................. I was going to pick this one for the contest....but....i didnt..........oh well... Tomorrow should be intersting.

Good luck to anyone holding

-fousc

Already a thread created: http://www.3stocksonfire.org/trading/index.php?topic=2303.msg16425#msg16425

Please do a search before posting.... 

Hi Calven,
FDA approval for INSM is a big news. AH volume was huge as well - just over 3 mln.

http://quotes.nasdaq.com/quote.dll?mode=frameset&kind=&symbol=VPHM&symbol=NVAX&symbol=INSM&symbol=&symbol=&symbol=&symbol=&symbol=&symbol=&symbol=&selected=INSM&FormType=&mkttype=AFTER&pathname=&page=afterhours

I'm in AH at $2.17

Tomorrow's CC at 8am will provide more info.

"...FDA Approval of iPlex & Corporate Update Conference Call
Scheduled to start Tue, Dec 13, 2005, 8:00 am Eastern

Check back at the scheduled start time for
the audio link to appear in this spot.

Add this event to your Yahoo! Calendar Add This Event To Your Yahoo! Calendar

About Insmed Incorporated (NasdaqNM:INSM)   
Insmed Incorporated, a biopharmaceutical company, engages in the discovery and development of drug candidates for the treatment of metabolic diseases and endocrine disorders. Its lead product includes recombinant human insulin-like growth factor-I bound to recombinant human insulin-like growth factor binding protein-3 (rhIGF-I/rhIGFBP-3), a Phase III clinical trial product, which would be used for the treatment of severe growth disturbance due to growth hormone insensitivity syndrome. The company's research and development stage products include rhIGFBP-3, for the treatment of various cancers; and INSM-18, for the treatment of various tumors. The company has strategic relationships with Fujisawa Pharmaceutical Co., Ltd.; Tzamal Pharmaceutical; Pharmacia, Inc.; and Avecia Limited. Insmed was incorporated in 1999 and is based in Glen Allen, Virginia...."

http://biz.yahoo.com/cc/8/63308.html

GLTA,

Gielda

Thanks for the post gielda2003 ! INSM at 2.32 AH now....


Things look good for tomorrow. I think it could run to just over 3.00 tomorrow if this news is as good as i think it is...then 4.00 longer term!

• 
  PLEASE VIEW THIS: http://shortsqueeze.com/index.php?PHPSESSID=36a200193090ec9c1951a0f2f1c398d4&symbol=INSM

It will take 9.8 days for short to cover their position...

Short interest is huge. Shorts will wake up tomorrow with a 60% loss and be forced to cover!



cal

Calven,
Many posters on Yahoo compare possible INSM run with the SPEX run. I know SPEX is low floater, but what is your take, if you don't mind.
Kindly appreciate your feedback,

Gielda

I expect 4.00 because of the short % of float..... 

3.00 would be tomorrow's "short term" target